Under the leadership of John Ramunas and Glenn Markov, Rejuvenation Technologies is developing RTI-LIV for Alcoholic Hepatitis. Their focus is on reversing telomere shortening, a fundamental hallmark of aging, to combat age-related diseases.
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.